INDEMNIFICATION AGREEMENTIndemnification Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of ________ __, 20__ by and between Generation Bio Co., a Delaware corporation (the “Company”), and ______________ (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement. [[Solely with respect to officers and directors that execute this form of indemnification agreement on or prior to the Company’s initial public offering:] and shall be effective as of the effectiveness of a Registration Statement on Form S-1 relating to the initial registration under the Securities Act of 1933, as amended, of shares of the Company’s common stock].
Generation Bio Co. STOCK OPTION AGREEMENTStock Option Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
GENERATION BIO CO. STOCK OPTION AGREEMENT GRANTED UNDER 2017 STOCK INCENTIVE PLANStock Option Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations
This Stock Option Agreement (this “Agreement”) is made between Generation Bio Co., a Delaware corporation (the “Company”), and the Participant pursuant to the 2017 Stock Incentive Plan (the “Plan”).
Generation Bio Co. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Delaware
This restricted stock award satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
CONSULTING AGREEMENTConsulting Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is made effective as of September 26, 2019 (the “Effective Date”), by and between Generation Bio Co., a Delaware corporation, with its principal place of business being 301 Binney Street, Suite 401, Cambridge, MA 02142 (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability corporation, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
GENERATION BIO CO. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 9th day of January, 2020, by and among Generation Bio Co., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
Generation Bio Co. RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Delaware
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
GENERATION BIO CO. CONSULTING AGREEMENTConsulting Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”), made this 5th day of January, 2019 is entered into by Generation Bio Co., a Delaware corporation (the “Company”), and Tom Graney, an individual residing at (the “Consultant”).
January 9, 2020Stock Option Agreement • May 22nd, 2020 • Generation Bio Co. • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Agreement”) memorializes our recent discussions regarding the decision of Generation Bio (the “Company”)1 to end your employment, which coincided with your need for short-term disability leave. As discussed, the Company has agreed to postpone the effective date of your separation until the conclusion of your short-term disability leave. This Agreement also sets forth our agreement concerning the severance benefits to be made available to you at the time your employment at the Company ends and other terms and conditions to which we have agreed in connection with your leave and separation. This Agreement will become effective and enforceable on the eighth day after you sign it without revocation (the “Effective Date”).
